Olimel 5.7% E 121 g

OlimeL 5.7% E 121 G is an intravenous emulsion containing dextrose, designed for nutritional support. This product, manufactured by Baxter Corporation in Canada, is available in various pack sizes for medical use.

OlimeL 5.7% E 121 G is primarily used for intravenous nutrition, providing essential carbohydrates to support energy needs. It is often utilized in clinical settings where oral intake is insufficient or not possible, such as during surgery recovery or certain medical conditions. This emulsion helps maintain blood sugar levels and supports overall metabolic function.

When administered intravenously, OlimeL 5.7% E 121 G provides a quick source of energy by delivering dextrose directly into the bloodstream. This can help stabilize blood glucose levels and support the body's energy requirements. The emulsion is designed to be well-tolerated, but individual responses may vary.

OlimeL 5.7% E 121 G should be administered under medical supervision to ensure proper dosage and monitoring. It is important to follow healthcare provider instructions regarding administration and storage. Patients with certain medical conditions, such as diabetes, should be closely monitored during use.

OlimeL 5.7% E 121 G may interact with other medications or supplements, particularly those affecting blood sugar levels. It is important to inform healthcare providers about all current medications before starting this treatment. Additionally, interactions with other intravenous solutions should be considered to avoid complications.